Health

Scientific publication

Secukinumab, a novel anti-IL-17A antibody, can be quantified in skin after a single dose by dermal open flow microperfusion (dOFM)

Publication from Health

Bruin G., Dragatin C. , Aigner B., Polus F., Calonder C., Froeliger C., Katrin Tiffner, Manfred Bodenlenz, Mader J., Korsatko S., Ratzer R., Prof Dr Thomas Pieber, Loesche C., Dr Frank Sinner

Journal der Deutschen Dermatologischen Gesellschaft 12:15-15, 2014